These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 37378942)
1. Deregulation of miR-10b and miR-21 Correlate with Cancer Stem Cells Expansion through the Apoptotic Pathway in Prostate Cancer. Shukla KK; Choudhary GR; Sankanagoudar S; Misra S; Vishnoi JR; Pareek P; Pilla KK; Pandey SN; Sharma P Asian Pac J Cancer Prev; 2023 Jun; 24(6):2105-2119. PubMed ID: 37378942 [TBL] [Abstract][Full Text] [Related]
2. Role of miRNA-145, 148, and 185 and Stem Cells in Prostate Cancer. Coradduzza D; Cruciani S; Arru C; Garroni G; Pashchenko A; Jedea M; Zappavigna S; Caraglia M; Amler E; Carru C; Maioli M Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163550 [TBL] [Abstract][Full Text] [Related]
3. IMPORTANCE OF APOPTOSIS MARKERS (MDM2, BCL-2 AND Bax) IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER. Saker Z; Tsintsadze O; Jiqia I; Managadze L; Chkhotua A Georgian Med News; 2015 Dec; (249):7-14. PubMed ID: 26719543 [TBL] [Abstract][Full Text] [Related]
4. miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions. Hagman Z; Larne O; Edsjö A; Bjartell A; Ehrnström RA; Ulmert D; Lilja H; Ceder Y Int J Cancer; 2010 Dec; 127(12):2768-76. PubMed ID: 21351256 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer. Zidan HE; Abdul-Maksoud RS; Elsayed WSH; Desoky EAM IUBMB Life; 2018 May; 70(5):437-444. PubMed ID: 29522280 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer. Rönnau CGH; Fussek S; Smit FP; Aalders TW; van Hooij O; Pinto PMC; Burchardt M; Schalken JA; Verhaegh GW World J Urol; 2021 Oct; 39(10):3789-3797. PubMed ID: 33990872 [TBL] [Abstract][Full Text] [Related]
7. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method. Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988 [TBL] [Abstract][Full Text] [Related]
8. Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia. Jin W; Fei X; Wang X; Chen F; Song Y J Immunol Res; 2020; 2020():5873056. PubMed ID: 32455140 [TBL] [Abstract][Full Text] [Related]
9. Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer. Guzel E; Karatas OF; Semercioz A; Ekici S; Aykan S; Yentur S; Creighton CJ; Ittmann M; Ozen M Int J Cancer; 2015 Feb; 136(4):875-9. PubMed ID: 24976077 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-99b-5p targets mTOR/AR axis, induces autophagy and inhibits prostate cancer cell proliferation. Niture S; Tricoli L; Qi Q; Gadi S; Hayes K; Kumar D Tumour Biol; 2022; 44(1):107-127. PubMed ID: 35811549 [TBL] [Abstract][Full Text] [Related]
11. MiR-139-5p is Increased in the Peripheral Blood of Patients with Prostate Cancer. Pang C; Liu M; Fang W; Guo J; Zhang Z; Wu P; Zhang Y; Wang J Cell Physiol Biochem; 2016; 39(3):1111-7. PubMed ID: 27562849 [TBL] [Abstract][Full Text] [Related]
12. Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status. Leidinger P; Hart M; Backes C; Rheinheimer S; Keck B; Wullich B; Keller A; Meese E Tumour Biol; 2016 Aug; 37(8):10177-85. PubMed ID: 26831660 [TBL] [Abstract][Full Text] [Related]
13. Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases. Dülgeroğlu Y; Eroğlu O Microrna; 2020; 9(4):303-309. PubMed ID: 33155933 [TBL] [Abstract][Full Text] [Related]
14. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone. Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843 [TBL] [Abstract][Full Text] [Related]
15. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition. Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2. Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4. Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117 [TBL] [Abstract][Full Text] [Related]
18. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche. Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257 [TBL] [Abstract][Full Text] [Related]
19. Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E. Song Y; Song C; Yang S Cancer Biother Radiopharm; 2018 Jun; 33(5):203-211. PubMed ID: 29916747 [TBL] [Abstract][Full Text] [Related]
20. miRNA-21 as High Potential Prostate Cancer Biomarker in Prostate Cancer Patients in Indonesia. Gunawan RR; Astuti I; Danarto HR Asian Pac J Cancer Prev; 2023 Mar; 24(3):1095-1099. PubMed ID: 36974566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]